![Michael Secora](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Secora
Finansdirektör/CFO på
Entos, Inc.
Profil
Dr. Michael Secora is a Chief Financial & Corporate Development Officer at Iambic Therapeutics, Inc. Dr. Secora was previously employed as a Chief Financial Officer by Recursion Pharmaceuticals, Inc. and a Portfolio Management by Laurion Capital Management LP.
He received his undergraduate degree from Massachusetts Institute of Technology and a doctorate degree from Princeton University.
Aktiva positioner av Michael Secora
| Företag | Position | Start |
|---|---|---|
Entos, Inc.
 Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Finansdirektör/CFO | 2025-01-01 |
Tidigare kända positioner av Michael Secora
| Företag | Position | Slut |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2024-11-20 |
Laurion Capital Management LP
 Laurion Capital Management LP Investment ManagersFinance LCM seeks to generate attractive returns on capital with controlled exposure to market direction. Their fund aims to profit from a global multi-disciplinary approach that uses a variety of trading strategies, including, among others, volatility trading strategies, model-based strategies, relative value strategies, event-driven strategies, and discretionary and macro-style trading strategies. It invests in a broad array of securities and derivatives under a range of different market scenarios, making use of these and other strategies. | Portföljförvaltare-Aktier | 2020-01-01 |
Michael Secoras utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
37
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Recursion Pharmaceuticals, Inc.
 Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laurion Capital Management LP
Laurion Capital Management LP Investment ManagersFinance LCM seeks to generate attractive returns on capital with controlled exposure to market direction. Their fund aims to profit from a global multi-disciplinary approach that uses a variety of trading strategies, including, among others, volatility trading strategies, model-based strategies, relative value strategies, event-driven strategies, and discretionary and macro-style trading strategies. It invests in a broad array of securities and derivatives under a range of different market scenarios, making use of these and other strategies. | Finance |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Technology Services |
